ADAP – Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plcADAP
$0.2581Name : Adaptimmune Therapeutics plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $66,391,580.00
EPSttm : -0.3
Adaptimmune Therapeutics plc
$0.2581
20.31%$0.0658Float Short %
2.49
Margin Of Safety %
Put/Call OI Ratio
0.02
EPS Next Q Diff
0.13
EPS Last/This Y
-0.19
EPS This/Next Y
Price
0.26
Target Price
2.27
Analyst Recom
2
Performance Q
-58.6
Relative Volume
1.18
Beta
2.62
Ticker: ADAP
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-06 | ADAP | 0.4989 | 0.03 | 0.00 | 4416 |
| 2025-03-07 | ADAP | 0.4952 | 0.03 | 0.00 | 4419 |
| 2025-03-10 | ADAP | 0.45 | 0.03 | 0.00 | 4480 |
| 2025-03-11 | ADAP | 0.4427 | 0.03 | 0.00 | 4485 |
| 2025-03-12 | ADAP | 0.468 | 0.03 | 0.34 | 4530 |
| 2025-03-13 | ADAP | 0.4458 | 0.04 | 0.00 | 4555 |
| 2025-03-14 | ADAP | 0.4496 | 0.04 | 0.00 | 4553 |
| 2025-03-17 | ADAP | 0.4502 | 0.04 | 0.02 | 4581 |
| 2025-03-18 | ADAP | 0.4545 | 0.04 | 0.03 | 4615 |
| 2025-03-19 | ADAP | 0.448 | 0.04 | 0.00 | 4630 |
| 2025-03-20 | ADAP | 0.2872 | 0.04 | 0.25 | 4672 |
| 2025-03-21 | ADAP | 0.2908 | 0.04 | 0.54 | 4841 |
| 2025-03-24 | ADAP | 0.2789 | 0.02 | 0.07 | 2835 |
| 2025-03-25 | ADAP | 0.255 | 0.02 | 0.10 | 2884 |
| 2025-03-26 | ADAP | 0.2301 | 0.02 | 1.80 | 2974 |
| 2025-03-27 | ADAP | 0.221 | 0.03 | 33.00 | 3007 |
| 2025-03-28 | ADAP | 0.2077 | 0.04 | 13.00 | 3083 |
| 2025-03-31 | ADAP | 0.1991 | 0.05 | 6.67 | 3104 |
| 2025-04-01 | ADAP | 0.2535 | 0.06 | 0.59 | 3133 |
| 2025-04-02 | ADAP | 0.3062 | 0.05 | 0.05 | 3157 |
| 2025-04-03 | ADAP | 0.3297 | 0.05 | 0.02 | 3512 |
| 2025-04-04 | ADAP | 0.2582 | 0.02 | 0.00 | 3743 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-06 | ADAP | 0.49 | 35.8 | - | -0.14 |
| 2025-03-07 | ADAP | 0.50 | 35.8 | - | -0.14 |
| 2025-03-10 | ADAP | 0.45 | 35.8 | - | -0.14 |
| 2025-03-11 | ADAP | 0.44 | 35.8 | - | -0.14 |
| 2025-03-12 | ADAP | 0.46 | 35.8 | - | -0.14 |
| 2025-03-13 | ADAP | 0.44 | 35.8 | - | -0.14 |
| 2025-03-14 | ADAP | 0.45 | 35.8 | - | -0.14 |
| 2025-03-17 | ADAP | 0.46 | 35.8 | - | -0.14 |
| 2025-03-18 | ADAP | 0.46 | 35.8 | - | -0.14 |
| 2025-03-19 | ADAP | 0.45 | 35.8 | - | -0.14 |
| 2025-03-20 | ADAP | 0.28 | 35.8 | - | -0.14 |
| 2025-03-21 | ADAP | 0.29 | 35.8 | - | -0.14 |
| 2025-03-24 | ADAP | 0.28 | 35.8 | - | -0.14 |
| 2025-03-25 | ADAP | 0.25 | 35.8 | - | -0.14 |
| 2025-03-26 | ADAP | 0.23 | 35.8 | - | -0.14 |
| 2025-03-27 | ADAP | 0.22 | 35.8 | - | -0.14 |
| 2025-03-28 | ADAP | 0.21 | 8.3 | - | -0.49 |
| 2025-03-31 | ADAP | 0.20 | 8.3 | - | -0.49 |
| 2025-04-01 | ADAP | 0.25 | 8.3 | - | -0.49 |
| 2025-04-02 | ADAP | 0.31 | 8.3 | - | -0.49 |
| 2025-04-03 | ADAP | 0.33 | 8.3 | - | -0.49 |
| 2025-04-04 | ADAP | 0.26 | 8.3 | - | -0.49 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-06 | ADAP | -0.61 | -37.38 | 3.18 |
| 2025-03-07 | ADAP | -0.61 | -37.38 | 3.18 |
| 2025-03-10 | ADAP | -0.61 | -37.38 | 3.18 |
| 2025-03-11 | ADAP | -0.61 | -37.38 | 3.18 |
| 2025-03-12 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-13 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-14 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-17 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-18 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-19 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-20 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-21 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-24 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-25 | ADAP | -0.61 | -37.38 | 2.81 |
| 2025-03-26 | ADAP | -0.61 | -37.38 | 2.49 |
| 2025-03-27 | ADAP | -0.61 | -37.38 | 2.49 |
| 2025-03-28 | ADAP | -0.61 | -37.38 | 2.49 |
| 2025-03-31 | ADAP | -0.61 | -37.26 | 2.49 |
| 2025-04-01 | ADAP | -0.61 | -37.26 | 2.49 |
| 2025-04-02 | ADAP | -0.61 | -37.26 | 2.49 |
| 2025-04-03 | ADAP | -0.61 | -37.26 | 2.49 |
| 2025-04-04 | ADAP | -0.61 | -37.26 | 2.49 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.26
Avg. EPS Est. Current Quarter
-0.17
Avg. EPS Est. Next Quarter
-0.13
Insider Transactions
-0.61
Institutional Transactions
-37.26
Beta
2.62
Average Sales Estimate Current Quarter
7
Average Sales Estimate Next Quarter
9
Fair Value
Quality Score
32
Growth Score
57
Sentiment Score
86
Actual DrawDown %
98.1
Max Drawdown 5-Year %
-98.3
Target Price
2.27
P/E
Forward P/E
PEG
P/S
0.37
P/B
5.57
P/Free Cash Flow
EPS
-0.29
Average EPS Est. Cur. Y
-0.49
EPS Next Y. (Est.)
-0.49
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
-39.31
Relative Volume
1.18
Return on Equity vs Sector %
-617.4
Return on Equity vs Industry %
-604.5
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
Adaptimmune Therapeutics plcSector: Healthcare
Industry: Biotechnology
Employees: 506
Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA, a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment of people with synovial sarcoma and myxoid liposarcoma; ADP-5701 for a Phase 1 trial in Head and Neck Cancer. The company has strategic collaboration with Galapagos to clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel produced on Galapagos' decentralized manufacturing platform (ADP-5701) in patients with head and neck cancer; third-party collaborations with Noile-Immune and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
stock quote shares ADAP – Adaptimmune Therapeutics plc Stock Price stock today
news today ADAP – Adaptimmune Therapeutics plc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADAP – Adaptimmune Therapeutics plc yahoo finance google finance
stock history ADAP – Adaptimmune Therapeutics plc invest stock market
stock prices ADAP premarket after hours
ticker ADAP fair value insiders trading